EXOZYMES INC. (EXOZ) — Institutional Holders, Q2 2026
9 institutional investment managers reported a EXOZ position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.0M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
EXOZ in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
New positions
2
Added to
4
Trimmed
1
Sold out
0
Biggest buyers
- VANGUARD CAPITAL MANAGEMENTAdded · +32,795 sh+$276.5K
- Davidson Kahn Capital ManagementNew · +25,000 sh+$210.7K
- BlackRockAdded · +2,813 sh+$23.7K
- GEODE CAPITAL MANAGEMENTAdded · +1,515 sh+$12.8K
- UBS Group AGAdded · +179 sh+$1.5K
Biggest sellers
- Tower Research Capital (TRC)Trimmed · -968 sh-$8.2K
EXOZ 13F holders ranked 1–9 of 9
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT#1 · 54,985 sh | 54,985 | $463.5K | 0.00% | +147.8% |
| 2 | Davidson Kahn Capital Management#2 · 25,000 sh | 25,000 | $210.8K | — | New |
| 3 | GEODE CAPITAL MANAGEMENT#3 · 23,406 sh | 23,406 | $197.3K | 0.00% | +6.9% |
| 4 | BlackRock#4 · 9,610 sh | 9,610 | $81.0K | 0.00% | +41.4% |
| 5 | VANGUARD FIDUCIARY#5 · 9,426 sh | 9,426 | $79.5K | 0.00% | 0.0% |
| 6 | MORGAN STANLEY#6 · 1,250 sh | 1,250 | $10.5K | 0.00% | 0.0% |
| 7 | Tower Research Capital (TRC)#7 · 349 sh | 349 | $2.9K | <0.01% | -73.5% |
| 8 | UBS Group AG#8 · 203 sh | 203 | $1.7K | 0.00% | +745.8% |
| 9 | BARCLAYS PLC#9 · 75 sh | 75 | $632.00 | 0.00% | New |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.